Advanced Proficiency Testing: Applications in Laboratory Networks
Expires: March 11, 2022
Video length: 33 minutes
Proficiency Testing (PT) has been a regular part of laboratory compliance since CLIA laws were passed in 1988. But as labs have evolved, and especially as groups of labs have formed health systems and networks, PT compliance must be reassessed.
This Continual Improvement Webinar will highlight differences in proficiency testing practices in laboratory networks, discuss possible pitfalls and strategies to reduce risk, and examine regulatory changes and ways to adapt to them at the network level. Additionally, examples of procedure development, methodologies and tools will also be reviewed.
Deborah J. Wells
Quality Assurance Manager
Department of Laboratory Medicine and Pathology
Mayo Clinic, Rochester, Minnesota
Upon completion of this activity, participants should be able to:
- Define three (3) critical differences between complying with PT regulations in a single lab versus within a health system or laboratory network.
- Describe the role of the Laboratory Information System (LIS) in PT compliance.
- Develop system-level PT policies and practices that facilitate improved PT compliance.
- Apply principles of improved compliance to your laboratories.
This series is appropriate for laboratory administrators and managers, quality assurance and control staff, supervisors, and other laboratory personnel who are dedicated to continuous quality and process improvement.
The following types of credit are offered for this event:
To obtain credit:
- Watch the video.
- Complete the posttest and evaluation that launches immediately following the video.
- Generate and print your certificate(s).
Level of instruction for this program is intermediate.
Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 0.5 P.A.C.E.® contact hour.
Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.
Contact us: email@example.com